defuse 3 trial

0:03:10

DEFUSE 3

0:02:08

Stroke Clinical Trials – DEFUSE 3 & DAWN Trials

0:06:30

Emergency Medicine | DEFUSE 3 Trial - Thrombectomy for Stroke at 6 to 16 Hours | Raaonline

0:27:31

DEFUSE 3 and Recent Stroke Trials - Prof P N Sylaja

0:11:13

DEFUSE 3: Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

0:53:22

Transnational VIR Journal Club (TNVIRJC) Session 12: DAWN and DEFUSE-3 Trials

0:03:01

DEFUSE 3 Stanford Stroke Center iRAPID iSchemaview

0:01:46

2019 Clinical Research Forum Top Ten | Defuse 3 Study

0:03:46

New Ways to Treat Patients with Large Vessel Occlusions

0:03:01

The DAWN Trial - Acture Stroke Intervention by Benjamin L. Brown, MD | Preview

0:02:05

Extending the use of mechanical thrombectomy in stroke

0:02:43

DAWN Trial

0:01:18

Updated Stroke Treatment Guidelines | The Morning Report

0:53:01

CT Perfusion In Acute Ischemic Stroke

0:04:42

Endovascular therapy vs medical management for large core ischemic stroke: ANGEL-ASPECT results

0:03:40

Should wake-up stroke patients be treated as late-window patients?

0:02:32

MR CLEAN-LATE shows benefit of EVT in the late time window for patients with collaterals

1:02:00

Dr. Amrou Sarraj, MD - Endovascular thrombectomy for large core ischemic stroke

0:06:25

ESCAPE NA1 Trial

0:03:07

Endovascular Thrombectomy and Outcomes in Ischemic Stroke

0:21:23

Pivotal Stroke Trials Presented at this Year’s ESOC

0:01:52

ECASS 3: The Trial That Expanded the Use of TPA in Ischemic Stroke

0:01:12

Sandoz launches Phase III Clinical Trial for biosimilar Etanercept

1:03:42

SIR-RFS Webinar (6/5/2018): Updates on Endovascular Therapy for Acute Ischemic Stroke